Clinical Research Studies
The Skin and Laser Treatment Institute is enrolling Clinical Research Studies for the following therapeutics:
Why are we conducting this research?
We are conducting this study to look at whether an investigational drug is safe and effective in treating individuals with moderate to severe Plaque Psoriasis and Atopic Dermatitis.
What will happen if I join?
If you would like to join, we will ask you to sign an informed consent form to understand key information about the study, including purpose, procedures, risks and benefits. Then, a study doctor will examine you and talk through your medical history to determine if you are eligible to participate. If you are, you will need to visit the study clinic for regular assessments. The investigational drug, study visits and any related medical assessments will be provided at no cost to you or your insurance company. You may be responsible for other costs (for example, assessments you would receive as the usual cost for your disease), some of which may be covered by your insurance.
Below are the minimum requirements needed for participation in our Clinical Research Studies:
ATOPIC DERMATITIS (ECZEMA)
If you are struggling with moderate to severe atopic dermatitis, this study could be an option for you. Qualified participants must:
- Have a diagnosis of Atopic Dermatitis for at least 3 years
- Be between the age of 12-75 years old
- Have had an inadequate response to topical medications in the last 6 months
- Have a documented history by a physician of inadequate response to existing topical medications within 6 months of screening, or history of intolerance to topical therapy
- Have at least 10% body surface area involvement
PLAQUE PSORIASIS
If you are an adult struggling with moderate to severe Plaque Psoriasis, this study could be an option for you. Qualified participants must:
- Be at least 18 years of age
- Have stable moderate-to-severe Plaque Psoriasis (for at least 6 months)
- Be a candidate for phototherapy or systemic therapy
- Have at least 10% body surface area involvement
